Abstract |
Bistropolone derivatives (4-12) containing differing lengths of linkage between the two tropolone rings were prepared and examined for their antitumor activity in in vitro (KB cell) and in vivo ( leukemia P388 in mice) systems. Parent compound 3, related compounds previously prepared, and the new compounds 4-12 were evaluated for inhibitory activity against ribonucleotide reductase by indirect means to measure their effects on the dNTP pool imbalance. Present structure-activity relationship results would suggest that potently active bistropolones in vivo inhibit intracellular ribonucleotide reductase through chelating with the two irons at the two active sites of the enzyme.
|
Authors | M Yamato, J Ando, K Sakaki, K Hashigaki, Y Wataya, S Tsukagoshi, T Tashiro, T Tsuruo |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 35
Issue 2
Pg. 267-73
(Jan 24 1992)
ISSN: 0022-2623 [Print] United States |
PMID | 1732542
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Deoxyribonucleotides
- Tropolone
|
Topics |
- Animals
- Antineoplastic Agents
(chemical synthesis, pharmacology)
- Deoxyribonucleotides
(metabolism)
- Leukemia P388
(drug therapy)
- Mice
- Structure-Activity Relationship
- Tropolone
(analogs & derivatives, chemical synthesis, pharmacology)
- Tumor Cells, Cultured
(drug effects)
|